IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 649-660

  Roffê, Ester ^a   Rothfuchs, Antonio Gigliotti ^a,b   Santiago, Helton C ^a   Marino, Ana Paula M P ^a   Ribeiro Gomes, Flavia L ^a   Eckhaus, Michael ^c   Antonelli, Lis R V ^a,d   Murphy, Philip M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EFFECTOR CELL; HEART FAILURE; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFER; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PARASITE CONTROL; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPECIES COMPARISON; TRYPANOSOMA CRUZI; WILD TYPE;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMALS; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDITIS; PARASITEMIA; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS; TRYPANOSOMA CRUZI;

EID: 84856013800     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003845     Document Type: Article

References (41)

1. Schofield, C. J., J. Jannin, and R. Salvatella. 2006. The future of Chagas disease control. Trends Parasitol. 22: 583-588. (Pubitemid 44781088)
2. Urbina, J. A. 2010. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop. 115: 55-68.
3. Rocha, M. O., M. C. Nunes, and A. L. Ribeiro. 2009. Morbidity and prognostic factors in chronic chagasic cardiopathy. Mem. Inst. Oswaldo Cruz 104(Suppl 1): 159-166.
4. Marin-Neto, J. A., E. Cunha-Neto, B. C. Maciel, and M. V. Simões. 2007. Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109-1123. (Pubitemid 46679556)
5. Michailowsky, V., N. M. Silva, C. D. Rocha, L. Q. Vieira, J. Lannes-Vieira, and R. T. Gazzinelli. 2001. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am. J. Pathol. 159: 1723-1733. (Pubitemid 33062515)
6. Hardison, J. L., W. A. Kuziel, J. E. Manning, and T. E. Lane. 2006. Chemokine CC receptor 2 is important for acute control of cardiac parasitism but does not contribute to cardiac inflammation after infection with Trypanosoma cruzi. J. Infect. Dis. 193: 1584-1588. (Pubitemid 43794588)
7. Machado, F. S., N. S. Koyama, V. Carregaro, B. R. Ferreira, C. M. Milanezi, M. M. Teixeira, M. A. Rossi, and J. S. Silva. 2005. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J. Infect. Dis. 191: 627-636. (Pubitemid 40216680)
8. Hardison, J. L., R. A. Wrightsman, P. M. Carpenter, T. E. Lane, and J. E. Manning. 2006. The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infect. Immun. 74: 125-134. (Pubitemid 43023066)
9. Reis, M. M., Mde. L. Higuchi, L. A. Benvenuti, V. D. Aiello, P. S. Gutierrez, G. Bellotti, and F. Pileggi. 1997. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin. Immunol. Immunopathol. 83: 165-172.
10. Gomes, J. A., L. M. Bahia-Oliveira, M. O. Rocha, O. A. Martins-Filho, G. Gazzinelli, and R. Correa-Oliveira. 2003. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 71: 1185-1193. (Pubitemid 36254300)
11. Federici, E. E., W. H. Abelmann, and F. A. Neva. 1964. Chronic and progressive myocarditis and myositis in C3H mice infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 13: 272-280.
12. Reed, S. G., C. E. Brownell, D. M. Russo, J. S. Silva, K. H. Grabstein, and P. J. Morrissey. 1994. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 153: 3135-3140. (Pubitemid 24292538)
13. Abrahamsohn, I. A., and R. L. Coffman. 1996. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 84: 231-244.
14. Hunter, C. A., L. A. Ellis-Neyes, T. Slifer, S. Kanaly, G. Grünig, M. Fort, D. Rennick, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158: 3311-3316. (Pubitemid 127484048)
15. Hölscher, C., M. Mohrs, W. J. Dai, G. Köhler, B. Ryffel, G. A. Schaub, H. Mossmann, and F. Brombacher. 2000. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect. Immun. 68: 4075-4083. (Pubitemid 30434562)
16. Brener, Z. 1962. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. Sao Paulo 4: 389-396.
17. Santiago, H. C., C. G. Feng, A. Bafica, E. Roffe, R. M. Arantes, A. Cheever, G. Taylor, L. Q. Vieira, J. Aliberti, R. T. Gazzinelli, and A. Sher. 2005. Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hemopoiesis and intracellular control of parasite growth. J. Immunol. 175: 8165-8172. (Pubitemid 41798380)
18. Cummings, K. L., and R. L. Tarleton. 2003. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol. Biochem. Parasitol. 129: 53-59. (Pubitemid 36703222)
19. dos Santos, P. V., E. Roffê, H. C. Santiago, R. A. Torres, A. P. M. P. Marino, C. N. Paiva, A. A. Silva, R. T. Gazzinelli, and J. Lannes-Vieira. 2001. Prevalence of CD8(+)α β T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-γ-inducible adhesion and chemoattractant molecules. Microbes Infect. 3: 971-984. (Pubitemid 32913696)
20. Talvani, A., C. S. Ribeiro, J. C. Aliberti, V. Michailowsky, P. V. Santos, S. M. Murta, A. J. Romanha, I. C. Almeida, J. Farber, J. Lannes-Vieira, et al. 2000. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect. 2: 851-866. (Pubitemid 30483180)
21. Michailowsky, V., M. R. Celes, A. P. Marino, A. A. Silva, L. Q. Vieira, M. A. Rossi, R. T. Gazzinelli, J. Lannes-Vieira, and J. S. Silva. 2004. Intercellular adhesion molecule 1 deficiency leads to impaired recruitment of T lymphocytes and enhanced host susceptibility to infection with Trypanosoma cruzi. J. Immunol. 173: 463-470. (Pubitemid 38797373)
22. Silva, A. A., E. Roffe, A. P. Marino, P. V. dos Santos, T. Quirico-Santos, C. N. Paiva, and J. Lannes-Vieira. 1999. Chagas' disease encephalitis: intense CD8+ lymphocytic infiltrate is restricted to the acute phase, but is not related to the presence of Trypanosoma cruzi antigens. Clin. Immunol. 92: 56-66. (Pubitemid 29315986)
23. Medeiros, G. A., J. C. Silvério, A. P. Marino, E. Roffê, V. Vieira, K. Kroll-Palhares, C. E. Carvalho, A. A. Silva, M. M. Teixeira, and J. Lannes-Vieira. 2009. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage. Microbes Infect. 11: 264-273.
24. Wrightsman, R., S. Krassner, and J. Watson. 1982. Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival. Infect. Immun. 36: 637-644. (Pubitemid 12101889)
25. Higuchi, Mde. L., P. S. Gutierrez, V. D. Aiello, S. Palomino, E. Bocchi, J. Kalil, G. Bellotti, and F. Pileggi. 1993. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch. A Pathol. Anat. Histopathol. 423: 157-160.
26. Reis, D. D., E. M. Jones, S. Tostes, Jr., E. R. Lopes, G. Gazzinelli, D. G. Colley, and T. L. McCurley. 1993. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am. J. Trop. Med. Hyg. 48: 637-644. (Pubitemid 23187192)
27. Rottenberg, M. E., M. Bakhiet, T. Olsson, K. Kristensson, T. Mak, H. Wigzell, and A. Orn. 1993. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect. Immun. 61: 5129-5133. (Pubitemid 23353889)
28. Silva, J. S., P. J. Morrissey, K. H. Grabstein, K. M. Mohler, D. Anderson, and S. G. Reed. 1992. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175: 169-174.
29. Gazzinelli, R. T., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 22: 2501-2506.
30. Jacobs, F., D. Chaussabel, C. Truyens, V. Leclerq, Y. Carlier, M. Goldman, and B. Vray. 1998. IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection. Clin. Exp. Immunol. 113: 59-64. (Pubitemid 28329066)
31. Kotner, J., and R. Tarleton. 2007. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect. Immun. 75: 861-869. (Pubitemid 46203450)
32. Mariano, F. S., F. R. Gutierrez, W. R. Pavanelli, C. M. Milanezi, K. A. Cavassani, A. P. Moreira, B. R. Ferreira, F. Q. Cunha, C. R. Cardoso, and J. S. Silva. 2008. The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect. 10: 825-833.
33. Jankovic, D., M. C. Kullberg, C. G. Feng, R. S. Goldszmid, C. M. Collazo, M. Wilson, T. A. Wynn, M. Kamanaka, R. A. Flavell, and A. Sher. 2007. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204: 273-283. (Pubitemid 46294544)
34. Sun, J., R. Madan, C. L. Karp, and T. J. Braciale. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15: 277-284.
35. Hölscher, C., G. Köhler, U. Müller, H. Mossmann, G. A. Schaub, and F. Brombacher. 1998. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66: 1208-1215. (Pubitemid 28101166)
36. Kroll-Palhares, K., J. C. Silvério, A. A. Silva, V. Michailowsky, A. P. Marino, N. M. Silva, C. M. Carvalho, L. M. Pinto, R. T. Gazzinelli, and J. Lannes-Vieira. 2008. TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade. Mem. Inst. Oswaldo Cruz 103: 375-385. (Pubitemid 352026444)
37. Tarleton, R. L. 2007. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 19: 430-434. (Pubitemid 47284855)
38. Campos, M. A., I. C. Almeida, O. Takeuchi, S. Akira, E. P. Valente, D. O. Procópio, L. R. Travassos, J. A. Smith, D. T. Golenbock, and R. T. Gazzinelli. 2001. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167: 416-423. (Pubitemid 32567807)
39. Oliveira, A. C., J. R. Peixoto, L. B. de Arruda, M. A. Campos, R. T. Gazzinelli, D. T. Golenbock, S. Akira, J. O. Previato, L. Mendonça- Previato, A. Nobrega, and M. Bellio. 2004. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J. Immunol. 173: 5688-5696. (Pubitemid 39392157)
40. Caetano, B. C., B. B. Carmo, M. B. Melo, A. Cerny, S. L. dos Santos, D. C. Bartholomeu, D. T. Golenbock, and R. T. Gazzinelli. 2011. Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi. J. Immunol. 187: 1903-1911.
41. Bafica, A., H. C. Santiago, R. Goldszmid, C. Ropert, R. T. Gazzinelli, and A. Sher. 2006. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177: 3515-3519. (Pubitemid 44359881)